Aus G, Hugosson J, Norlén L
Department of Urology, Göteborg University, Ostra Hospital, Sweden.
J Urol. 1995 Aug;154(2 Pt 1):460-5. doi: 10.1097/00005392-199508000-00033.
We investigate the long-term outcome of patients with prostate cancer treated with noncurative intent.
All 514 prostate cancer patients who died between 1988 and 1991 and who underwent either deferred or immediate hormonal treatment were followed from death until diagnosis.
In all patients with stage M0 disease at diagnosis the ultimate cancer mortality rate was 50%. Among the 65 patients who survived at least 10 years the mortality rate due to prostate cancer was 63%.
Mortality in patients with stage M0 prostate cancer was surprisingly high when followup exceeded 10 years.
我们研究了接受非根治性治疗的前列腺癌患者的长期预后。
对1988年至1991年间死亡且接受了延迟或即刻激素治疗的514例前列腺癌患者进行了从死亡至诊断的随访。
诊断时处于M0期疾病的所有患者的最终癌症死亡率为50%。在至少存活10年的65例患者中，前列腺癌导致的死亡率为63%。
当随访超过10年时，M0期前列腺癌患者的死亡率出奇地高。
